PharmaCorp Rx Inc.
PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. It offers prescription drug and custom compounding specialization services; weight loss and lifestyle management solutions, including health and wellness products; and convenience and confectionary products. The company was incorporated in 2021 and is headquartered in Saskatoon, Canada.
PharmaCorp Rx Inc. (PCRX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.018x
Based on the latest financial reports, PharmaCorp Rx Inc. (PCRX) has a cash flow conversion efficiency ratio of 0.018x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$550.26K) by net assets (CA$30.21 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
PharmaCorp Rx Inc. - Cash Flow Conversion Efficiency Trend (2022–2024)
This chart illustrates how PharmaCorp Rx Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
PharmaCorp Rx Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PharmaCorp Rx Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
RATH Aktiengesellschaft
VI:RAT
|
0.038x |
|
PT Eagle High Plantations Tbk
F:7B7
|
0.034x |
|
JCH Systems Inc
KQ:033320
|
0.126x |
|
Sakar Healthcare Limited
NSE:SAKAR
|
0.101x |
|
Cyberfuels Holding Company Inc.
PINK:CBRF
|
-0.028x |
|
Tplex Co. Ltd
KQ:081150
|
0.005x |
|
Ilji Technology Co. Ltd
KQ:019540
|
0.067x |
|
Sinil Pharmaceutical Co. Ltd
KQ:012790
|
0.017x |
Annual Cash Flow Conversion Efficiency for PharmaCorp Rx Inc. (2022–2024)
The table below shows the annual cash flow conversion efficiency of PharmaCorp Rx Inc. from 2022 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CA$30.57 Million | CA$124.97K | 0.004x | +101.79% |
| 2023-12-31 | CA$2.27 Million | CA$-519.46K | -0.228x | -416.33% |
| 2022-12-31 | CA$2.72 Million | CA$-120.18K | -0.044x | -- |